Actively Recruiting

Phase Not Applicable
All Genders
Healthy Volunteers
ID05670301

Flemish Joint Effort for Biomarker Profiling in Inflammatory Systemic Diseases

Led by University Hospital, Ghent · Updated on 2024-09-19

2500

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University Hospital, Ghent

Lead Sponsor

U

University Hospital, Antwerp

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying cytokine profiles and other potential biomarkers in patients with presumed or confirmed systemic inflammatory diseases. This prospective, observational study involves multiple centers in Flanders, Belgium, aiming to understand differences and changes in blood cytokines over time among various inflammatory conditions, and to assess the usefulness of cytokine profiling for diagnosis and monitoring. The study includes patients with autoinflammatory diseases, autoimmune diseases, hyperinflammatory syndromes, and systemic infections, alongside healthy controls for comparison. Participants will undergo blood sampling for cytokine and lipidomic profiling using the FEBRIS Cytokine Profile Assay, which measures various pro- and anti-inflammatory cytokines, along with serum amyloid A quantification. Blood samples will be collected every 3 to 6 months for up to four years, with additional leftover samples stored for future analyses. Patients starting biological treatments will also complete questionnaires about their health-related quality of life to help understand treatment effects and improve care. During the study, participants will provide blood samples when routine clinical blood draws occur, and researchers will collect clinical information such as age, sex, weight, disease status, symptoms, therapies, and health costs. The main outcome is the measurement of specific inflammatory cytokines in serum over the study period. The study monitors participants longitudinally, correlating biomarker data with clinical and genetic diagnoses and treatment responses, with involvement lasting up to 48 months.

CONDITIONS

Brief Title

Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Child or adult
  • Written informed consent
  • Suspected or confirmed systemic inflammatory disease, including autoinflammatory diseases, autoimmune diseases, hyperinflammatory diseases, or other systemic inflammatory conditions
  • Planned blood sample for diagnostic purposes with possibility to collect additional blood volume
Not Eligible

You will not qualify if you...

  • Confirmed localized infection with good response to first-line antibiotic treatment
  • Confirmed malignancy
  • Healthy volunteers may be included as controls if they meet healthy individual requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 48 months

Participants undergo blood sampling to measure inflammatory cytokines and other biomarkers for diagnostic purposes.

Blood samples collected every 3 to 6 months and additional samples collected during routine clinical blood draws

Long-term Monitoring

Duration - Up to 48 months

Participants are followed longitudinally with repeated blood sampling and assessments to correlate biomarkers with clinical outcomes and therapeutic effects.

Blood sampling every 3 to 6 months with additional questionnaires for participants starting biological treatment

Trial Site Locations

Total: 7 locations

1

UZ Antwerpen

Antwerp, Belgium

Actively Recruiting

2

ZNA

Antwerp, Belgium

Not Yet Recruiting

3

UZ Brussel

Brussels, Belgium

Actively Recruiting

4

Ghent University Hospital

Ghent, Belgium, 9000

Actively Recruiting

5

UGent

Ghent, Belgium

Active, Not Recruiting

6

Jessa Hospital

Hasselt, Belgium

Actively Recruiting

7

UHasselt

Hasselt, Belgium

Active, Not Recruiting

Loading map...

Research Team

F

Filomeen Haerynck

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

A Biospecimen Collection Study to Identify the Targets of Di...

Autoimmune Diseases

Actively Recruiting

12 locations

An Exploratory Clinical Study of the Safety and Efficacy of ...

Autoimmune Diseases

Actively Recruiting

2 locations

A Multicenter Access and Distribution Protocol for Unlicense...

Hematologic Malignancies

Actively Recruiting

142 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here